Researchers at the University of Pennsylvania have introduced ApexGO, a new AI-powered tool designed to enhance antibiotic candidates that may not be fully effective.
This method reportedly improves the potency of promising but imperfect antibiotics, marking a significant advancement in antibiotic discovery.
ApexGO has demonstrated an impressive success rate of 85% in laboratory tests, suggesting its potential impact on future antibiotic development.